CN106573944A - 作为抗菌剂的金(i)‑膦化合物 - Google Patents

作为抗菌剂的金(i)‑膦化合物 Download PDF

Info

Publication number
CN106573944A
CN106573944A CN201580027784.XA CN201580027784A CN106573944A CN 106573944 A CN106573944 A CN 106573944A CN 201580027784 A CN201580027784 A CN 201580027784A CN 106573944 A CN106573944 A CN 106573944A
Authority
CN
China
Prior art keywords
compound
microorganism
biomembrane
compounds according
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580027784.XA
Other languages
English (en)
Chinese (zh)
Inventor
I·福尔摩斯
A·奈勒
G·尼古塔-吉拉斯
J·鲍威尔
I·查尔斯
D·阿尔伯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auspherix Ltd
Original Assignee
Auspherix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1409402.3A external-priority patent/GB201409402D0/en
Priority claimed from GB201501967A external-priority patent/GB201501967D0/en
Application filed by Auspherix Ltd filed Critical Auspherix Ltd
Publication of CN106573944A publication Critical patent/CN106573944A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/12—Gold compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201580027784.XA 2014-05-28 2015-05-28 作为抗菌剂的金(i)‑膦化合物 Pending CN106573944A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1409402.3 2014-05-28
GBGB1409402.3A GB201409402D0 (en) 2014-05-28 2014-05-28 Anti-bacterial compounds
GB201501967A GB201501967D0 (en) 2015-02-06 2015-02-06 Anti-bacterial compounds
GB1501967.2 2015-02-06
PCT/GB2015/051551 WO2015181551A1 (en) 2014-05-28 2015-05-28 Gold (i)-phosphine compounds as anti-bacterial agents

Publications (1)

Publication Number Publication Date
CN106573944A true CN106573944A (zh) 2017-04-19

Family

ID=53284306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580027784.XA Pending CN106573944A (zh) 2014-05-28 2015-05-28 作为抗菌剂的金(i)‑膦化合物

Country Status (13)

Country Link
US (1) US20170226133A1 (enExample)
EP (1) EP3148555A1 (enExample)
JP (1) JP2017529357A (enExample)
KR (1) KR20170008762A (enExample)
CN (1) CN106573944A (enExample)
AU (1) AU2015265715A1 (enExample)
BR (1) BR112016027772A2 (enExample)
CA (1) CA2950385A1 (enExample)
EA (1) EA201692189A1 (enExample)
IL (1) IL249199A0 (enExample)
MX (1) MX2016015626A (enExample)
SG (1) SG11201609387UA (enExample)
WO (1) WO2015181551A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109970771A (zh) * 2019-04-12 2019-07-05 云南大学 多醚链取代的炔基金（i）配合物及其制备方法与应用
WO2021109292A1 (zh) * 2019-12-02 2021-06-10 南方科技大学 金化合物在制备抗菌剂中的应用
CN113135958A (zh) * 2021-04-08 2021-07-20 南京中医药大学 氮杂环卡宾硒-金化合物在制备抗耐碳青霉烯类鲍曼不动杆菌药物中的应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143889A1 (en) 2007-05-14 2008-11-27 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
EP3253214A1 (en) * 2015-02-06 2017-12-13 Auspherix Limited Methods for the inhibition and dispersal of biofilms using auranofin
EP3346840A4 (en) * 2015-09-08 2019-03-13 Nanyang Technological University PROCESS FOR INHIBITING THE QUORUM DETECTION IN PSEUDOMONAS AERUGINOSA
GB201521238D0 (en) * 2015-12-02 2016-01-13 Auspherix Ltd Anti-bacterial compounds
US20200368249A1 (en) * 2017-06-26 2020-11-26 Kyle H. ROHDE Activity of gold-complexed compounds against mycobacterium tuberculosis and mycobacterium abscessus
DE102019120052A1 (de) 2019-07-24 2021-01-28 SchäferRolls GmbH & Co. KG Technische Walze, insbesondere für die Papierherstellung, Verfahren zum Einbringen einer Polymerfaser in ein Leerrohr einer technischen Walze und Verwendung einer Polymerfaser

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014703A1 (en) * 1993-11-24 1995-06-01 Luminis Pty. Ltd. Triorganophosphinegold (i) thionucleobases with anti-tumor activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883546A (en) * 1973-08-01 1975-05-13 Smithkline Corp S-heterocyclic derivatives of phosphine or phosphite gold mercaptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014703A1 (en) * 1993-11-24 1995-06-01 Luminis Pty. Ltd. Triorganophosphinegold (i) thionucleobases with anti-tumor activity

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANTONY JOHNSON等: "Mechanistic Studies of Reactions of Benzenethiol with Methyl Derivatives of of Platinum(II) and Gold-(I) and -(III)", 《J.C.S. DALTON》 *
BILJANAĐ.GLIŠIĆ等: "Gold complexes as antimicrobial agents: an overview of different biological activities in relation to the oxidation state of the gold ion and the ligand structure", 《DALTON TRANS.》 *
CHRISTOPHER K. MIRABELLI等: "Correlation of the in Vitro Cytotoxic and in Vivo Antitumor Activities of Gold(1) Coordination Complexes", 《J. MED. CHEM.》 *
CORRY DECKER等: "Platinum(II), palladium(II), nickel(II), and gold(I) complexes of the "electrospray-friendly" thiolate ligands 4-SC5H4N- and 4-SC6H4OMe-", 《JOURNAL OF COORDINATION CHEMISTRY》 *
J. M. MADEIRA等: "The biological activity of auranofin: implications for novel treatment of diseases", 《INFLAMMOPHARMACOL》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109970771A (zh) * 2019-04-12 2019-07-05 云南大学 多醚链取代的炔基金（i）配合物及其制备方法与应用
CN109970771B (zh) * 2019-04-12 2021-07-13 云南大学 多醚链取代的炔基金（i）配合物及其制备方法与应用
WO2021109292A1 (zh) * 2019-12-02 2021-06-10 南方科技大学 金化合物在制备抗菌剂中的应用
CN113135958A (zh) * 2021-04-08 2021-07-20 南京中医药大学 氮杂环卡宾硒-金化合物在制备抗耐碳青霉烯类鲍曼不动杆菌药物中的应用
CN113135958B (zh) * 2021-04-08 2022-05-27 南京中医药大学 氮杂环卡宾硒-金化合物在制备抗耐碳青霉烯类鲍曼不动杆菌药物中的应用

Also Published As

Publication number Publication date
MX2016015626A (es) 2017-07-04
EA201692189A1 (ru) 2017-02-28
KR20170008762A (ko) 2017-01-24
EP3148555A1 (en) 2017-04-05
WO2015181551A1 (en) 2015-12-03
SG11201609387UA (en) 2016-12-29
CA2950385A1 (en) 2015-12-03
US20170226133A1 (en) 2017-08-10
IL249199A0 (en) 2017-01-31
JP2017529357A (ja) 2017-10-05
AU2015265715A1 (en) 2016-11-24
BR112016027772A2 (pt) 2017-08-15

Similar Documents

Publication Publication Date Title
CN106573944A (zh) 作为抗菌剂的金(i)‑膦化合物
CN106459116A (zh) 作为抗菌剂的金(i)‑膦化合物
EP3040076B1 (en) A composition comprising a non-peptide antibiotic and cysteamine
JP2016509584A (ja) 抗菌性組成物
JP2017534570A (ja) 有機物質の存在下で改善された安定性を有するヨードフォア組成物
EP3360547B1 (en) Bactericidal pharmaceutical composition comprising ibuprofen
EP3383879A1 (en) Anti-bacterial compounds based on amino-gold phosphine complexes
US20180020669A1 (en) Methods for the Inhibition and Dispersal of Biofilms
US20180360856A1 (en) Anti-bacterial compounds
EP4536359A1 (en) Multi-component pharmaceutical compositions and kits containing nitric oxide releasing compounds and methods of using same
WO2017093544A1 (en) Alkynyl phosphine gold complexes for treating bacterial infections
WO2016124936A1 (en) Inhibition of microbial persister cells
WO2017177073A1 (en) Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
CN118175994A (zh) 用于治疗生物膜病症和感染的组合物和方法
HK1220911B (en) A composition comprising a non-peptide antibiotic and cysteamine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170419

WD01 Invention patent application deemed withdrawn after publication